A detailed history of National Bank Of Canada transactions in Amgen Inc stock. As of the latest transaction made, National Bank Of Canada holds 815,734 shares of AMGN stock, worth $255 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
815,734
Previous 802,295 1.68%
Holding current value
$255 Million
Previous $231 Million 0.37%
% of portfolio
0.4%
Previous 0.42%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$268.87 - $324.56 $3.61 Million - $4.36 Million
13,439 Added 1.68%
815,734 $232 Million
Q4 2023

Feb 06, 2024

BUY
$255.7 - $288.46 $3.95 Million - $4.46 Million
15,452 Added 1.96%
802,295 $231 Million
Q3 2023

Oct 10, 2023

BUY
$218.65 - $271.46 $35 Million - $43.4 Million
159,940 Added 25.51%
786,843 $211 Million
Q2 2023

Jul 26, 2023

BUY
$214.27 - $253.37 $76.5 Million - $90.5 Million
357,182 Added 132.43%
626,903 $139 Million
Q1 2023

Apr 12, 2023

BUY
$225.79 - $275.2 $7.45 Million - $9.08 Million
32,986 Added 13.93%
269,721 $65.2 Million
Q4 2022

Jan 24, 2023

BUY
$229.03 - $291.01 $20.8 Million - $26.4 Million
90,630 Added 62.03%
236,735 $0
Q3 2022

Oct 13, 2022

SELL
$224.46 - $253.15 $3.91 Million - $4.41 Million
-17,405 Reduced 10.64%
146,105 $33.3 Million
Q2 2022

Jul 28, 2022

SELL
$230.71 - $256.74 $4.26 Million - $4.74 Million
-18,463 Reduced 10.15%
163,510 $40 Million
Q1 2022

May 05, 2022

BUY
$219.27 - $242.57 $17 Million - $18.8 Million
77,312 Added 73.87%
181,973 $45.4 Million
Q4 2021

Jan 24, 2022

BUY
$198.88 - $227.6 $20.8 Million - $23.8 Million
104,661 New
104,661 $23.5 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $167B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.